JP2012092103A5 - - Google Patents

Download PDF

Info

Publication number: JP2012092103A5
Authority: JP; Japan
Prior art keywords: alkyl; fluoro; chloro; bromo; hydrogen
Prior art date: 2011-10-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2011237399A

Other languages

English (en)

Japanese (ja)

Other versions

JP2012092103A (ja

Filing date

2011-10-28

Publication date

2013-01-17

2011-10-28 Application filed filed Critical

2012-05-17 Publication of JP2012092103A publication Critical patent/JP2012092103A/ja

2013-01-17 Publication of JP2012092103A5 publication Critical patent/JP2012092103A5/ja

Status Pending legal-status Critical Current

Links

125000000217 alkyl group Chemical group 0.000 claims 12
125000001153 fluoro group Chemical group F* 0.000 claims 7
229910052739 hydrogen Inorganic materials 0.000 claims 6
239000001257 hydrogen Substances 0.000 claims 6
150000002431 hydrogen Chemical class 0.000 claims 5
-1 hydroxy, amino Chemical group 0.000 claims 5
125000001309 chloro group Chemical group Cl* 0.000 claims 4
125000001246 bromo group Chemical group Br* 0.000 claims 3
125000003342 alkenyl group Chemical group 0.000 claims 2
125000001118 alkylidene group Chemical group 0.000 claims 2
125000000304 alkynyl group Chemical group 0.000 claims 2
125000003118 aryl group Chemical group 0.000 claims 2
125000001072 heteroaryl group Chemical group 0.000 claims 2
125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 claims 1
125000004432 carbon atom Chemical group C* 0.000 claims 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
125000004093 cyano group Chemical group *C#N 0.000 claims 1
125000000753 cycloalkyl group Chemical group 0.000 claims 1
150000003839 salts Chemical class 0.000 claims 1
0 **C1(*=C)c2c3nn[n](*)c3ccc2C2=C(*)C(*)C3CC12C(*)C3 Chemical compound **C1(*=C)c2c3nn[n](*)c3ccc2C2=C(*)C(*)C3CC12C(*)C3 0.000 description 1

JP2011237399A 2004-12-09 2011-10-28 エストロゲン受容体モジュレーター Pending JP2012092103A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63478504P	2004-12-09	2004-12-09
US60/634,785		2004-12-09

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2007545542A Division JP2008523065A (ja)	2004-12-09	2005-12-05	エストロゲン受容体モジュレーター

Publications (2)

Publication Number	Publication Date
JP2012092103A JP2012092103A (ja)	2012-05-17
JP2012092103A5 true JP2012092103A5 (2)	2013-01-17

Family

ID=36578441

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2007545542A Withdrawn JP2008523065A (ja)	2004-12-09	2005-12-05	エストロゲン受容体モジュレーター
JP2011237399A Pending JP2012092103A (ja)	2004-12-09	2011-10-28	エストロゲン受容体モジュレーター

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
JP2007545542A Withdrawn JP2008523065A (ja)	2004-12-09	2005-12-05	エストロゲン受容体モジュレーター

Country Status (15)

Country	Link
US (1)	US7511152B2 (2)
EP (1)	EP1827421B1 (2)
JP (2)	JP2008523065A (2)
KR (1)	KR20070085874A (2)
CN (1)	CN101087606B (2)
AU (1)	AU2005314230B2 (2)
BR (1)	BRPI0518874A2 (2)
CA (1)	CA2590860C (2)
IL (1)	IL183543A (2)
MX (1)	MX2007006878A (2)
NO (1)	NO20073511L (2)
NZ (1)	NZ555316A (2)
RU (1)	RU2394820C2 (2)
WO (1)	WO2006062876A2 (2)
ZA (1)	ZA200704223B (2)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008524221A (ja) *	2004-12-17	2008-07-10	バイオノボ・インコーポレーテッド	Ｅｐｉｍｅｄｉｕｍ属植物の抽出液を用いた方法
US7482029B2 (en) *	2005-04-01	2009-01-27	Bionovo, Inc.	Composition for treatment of menopause
EP1943224B1 (en) *	2005-10-05	2011-07-27	Merck Sharp & Dohme Corp.	Estrogen receptor modulators
US7700136B2 (en) *	2005-11-14	2010-04-20	Bionovo, Inc.	Scutellaria barbata extract for the treatment of cancer
US9604931B2 (en)	2007-01-22	2017-03-28	Gtx, Inc.	Nuclear receptor binding agents
EA026578B1 (ru)	2007-01-22	2017-04-28	ДЖиТиЭкс, ИНК.	Вещества, связывающие ядерные рецепторы
US9623021B2 (en)	2007-01-22	2017-04-18	Gtx, Inc.	Nuclear receptor binding agents
US20080319051A1 (en) *	2007-06-22	2008-12-25	Bionovo, Inc.	Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) *	2007-06-22	2009-02-12	Bionovo, Inc.	Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
WO2009021196A1 (en) *	2007-08-08	2009-02-12	Bionovo, Inc.	Extracts of ligustrum lucidum and uses thereof
JP2010539086A (ja) *	2007-09-07	2010-12-16	バイオノボ・インコーポレーテッド	マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
US9155770B2 (en) *	2007-09-07	2015-10-13	Bionovo, Inc.	Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
JP2010539085A (ja) *	2007-09-07	2010-12-16	バイオノボ・インコーポレーテッド	マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
WO2009033025A1 (en) *	2007-09-07	2009-03-12	Bionovo, Inc.	Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
EP2222321A4 (en) *	2007-11-19	2013-02-13	Bionovo Inc	THERAPY AGAINST CANCER WITH AN EXTRACT OF SCUTELLARIA BARBATA
EP2219659A4 (en)	2007-11-19	2010-11-17	Bionovo Inc	METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
US20090130118A1 (en) *	2007-11-19	2009-05-21	Bionovo, Inc.	Scutellaria barbata extract and combinations for the treatment of cancer
CA2706330A1 (en) *	2007-11-19	2009-06-04	Bionovo, Inc.	A process of making purified extract of scutellaria barbata d. don
US20090258942A1 (en) *	2008-04-14	2009-10-15	Bionovo, Inc.	Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
EP2310024A4 (en) *	2008-05-06	2012-07-25	Bionovo Inc	ESTROGENIC EXTRACTS FOR THE TREATMENT OF VAGINA AND VULVAATROPHY
EP2294402A2 (en) *	2008-06-05	2011-03-16	Bionovo Inc.	Method of quantification of multiple bioactives from botanical compositons
US20090312437A1 (en) *	2008-06-06	2009-12-17	Bionovo, Inc., A Delaware Corporation	Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
EP2340027A4 (en) *	2008-09-03	2012-04-04	Bionovo Inc	METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
US20100303936A1 (en) *	2009-04-28	2010-12-02	Bionovo, Inc. A Delaware Corporation	Method of reducing fat accumulation and inducing weight loss
US9974776B2 (en)	2013-12-05	2018-05-22	Karo Pharma Ab	Estrogen receptor beta agonists for use in treating mesothelioma
CA3006683A1 (en) *	2015-12-22	2017-06-29	Jiangsu Hengrui Medicine Co., Ltd.	Benzopiperidine derivative, preparation method thereof and medical use thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4319039A (en)	1979-06-15	1982-03-09	Merck & Co., Inc.	Preparation of ammonium salt of hypocholesteremic fermentation product
US4294926A (en)	1979-06-15	1981-10-13	Merck & Co., Inc.	Hypocholesteremic fermentation products and process of preparation
US4231938A (en)	1979-06-15	1980-11-04	Merck & Co., Inc.	Hypocholesteremic fermentation products and process of preparation
US4444784A (en)	1980-08-05	1984-04-24	Merck & Co., Inc.	Antihypercholesterolemic compounds
DK149080C (da)	1980-06-06	1986-07-28	Sankyo Co	Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5889191A (ja)	1981-11-20	1983-05-27	Sankyo Co Ltd	３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US5354772A (en)	1982-11-22	1994-10-11	Sandoz Pharm. Corp.	Indole analogs of mevalonolactone and derivatives thereof
HU204253B (en)	1982-11-22	1991-12-30	Sandoz Ag	Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4911165A (en)	1983-01-12	1990-03-27	Ethicon, Inc.	Pliabilized polypropylene surgical filaments
US4681893A (en)	1986-05-30	1987-07-21	Warner-Lambert Company	Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4885314A (en)	1987-06-29	1989-12-05	Merck & Co., Inc.	Novel HMG-CoA reductase inhibitors
US4782084A (en)	1987-06-29	1988-11-01	Merck & Co., Inc.	HMG-COA reductase inhibitors
US4820850A (en)	1987-07-10	1989-04-11	Merck & Co., Inc.	Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5030447A (en)	1988-03-31	1991-07-09	E. R. Squibb & Sons, Inc.	Pharmaceutical compositions having good stability
US5180589A (en)	1988-03-31	1993-01-19	E. R. Squibb & Sons, Inc.	Pravastatin pharmaceuatical compositions having good stability
US4916239A (en)	1988-07-19	1990-04-10	Merck & Co., Inc.	Process for the lactonization of mevinic acids and analogs thereof
US5290946A (en)	1988-10-13	1994-03-01	Sandoz Ltd.	Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
US5118853A (en)	1988-10-13	1992-06-02	Sandoz Ltd.	Processes for the synthesis of 3-disubstituted aminoacroleins
US4929437A (en)	1989-02-02	1990-05-29	Merck & Co., Inc.	Coenzyme Q10 with HMG-CoA reductase inhibitors
US5189164A (en)	1989-05-22	1993-02-23	Sandoz Ltd.	Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
FI94339C (fi)	1989-07-21	1995-08-25	Warner Lambert Co	Menetelmä farmaseuttisesti käyttökelpoisen /R-(R,R)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5177080A (en)	1990-12-14	1993-01-05	Bayer Aktiengesellschaft	Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en)	1991-12-12	1993-03-29	Sandoz Ag	Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
US5298627A (en)	1993-03-03	1994-03-29	Warner-Lambert Company	Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
DE19523446A1 (de) *	1995-06-28	1997-01-02	Bayer Ag	Benzotriazole
DE60021254T2 (de)	1999-03-15	2006-04-20	AXYS Pharmaceuticals, Inc., South San Francisco	N-cyanomethylamide als protease inhibitoren
DE60132975T2 (de)	2000-01-06	2009-02-26	Merck Frosst Canada Inc., Kirkland	Neue substanzen und verbindungen als protease-inhibitoren
ATE524170T1 (de) *	2000-02-14	2011-09-15	Merck Sharp & Dohme	Östrogenrezeptor modulatoren
GB0012209D0 (en)	2000-05-19	2000-07-12	Novartis Ag	Organic compounds
CA2410201C (en) *	2000-06-20	2010-10-26	Novartis Ag	Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover
EP1339683B1 (en) *	2000-11-27	2006-06-14	Merck & Co., Inc.	Estrogen receptor modulators
WO2003015761A1 (en) *	2001-08-13	2003-02-27	Merck & Co., Inc.	Selective estrogen receptor modulators
WO2004027031A2 (en)	2002-09-19	2004-04-01	Merck & Co., Inc.	Tryptophan hydroxylase assay
AR051597A1 (es) *	2004-11-01	2007-01-24	Merck & Co Inc	Moduladores de los receptores de estrogeno

2005
- 2005-12-05 WO PCT/US2005/043859 patent/WO2006062876A2/en not_active Ceased
- 2005-12-05 KR KR1020077012865A patent/KR20070085874A/ko not_active Ceased
- 2005-12-05 US US11/792,729 patent/US7511152B2/en not_active Expired - Lifetime
- 2005-12-05 NZ NZ555316A patent/NZ555316A/en not_active IP Right Cessation
- 2005-12-05 BR BRPI0518874-1A patent/BRPI0518874A2/pt not_active IP Right Cessation
- 2005-12-05 AU AU2005314230A patent/AU2005314230B2/en not_active Ceased
- 2005-12-05 JP JP2007545542A patent/JP2008523065A/ja not_active Withdrawn
- 2005-12-05 RU RU2007125655/04A patent/RU2394820C2/ru not_active IP Right Cessation
- 2005-12-05 CA CA2590860A patent/CA2590860C/en not_active Expired - Fee Related
- 2005-12-05 CN CN2005800422962A patent/CN101087606B/zh not_active Expired - Fee Related
- 2005-12-05 MX MX2007006878A patent/MX2007006878A/es active IP Right Grant
- 2005-12-05 EP EP05852923.1A patent/EP1827421B1/en not_active Expired - Lifetime
2007
- 2007-05-22 ZA ZA200704223A patent/ZA200704223B/xx unknown
- 2007-05-29 IL IL183543A patent/IL183543A/en not_active IP Right Cessation
- 2007-07-06 NO NO20073511A patent/NO20073511L/no not_active Application Discontinuation
2011
- 2011-10-28 JP JP2011237399A patent/JP2012092103A/ja active Pending

Publication	Publication Date	Title
JP2012092103A5 (2)	2013-01-17
JP2016503793A5 (2)	2017-02-02
JP2011105738A5 (2)	2012-03-08
JP2010536766A5 (2)	2011-09-22
JP2009535462A5 (2)	2010-06-17
JP2010501534A5 (2)	2011-09-29
JP2010504286A5 (2)	2010-10-21
JP2013537203A5 (2)	2014-05-22
JP2013521295A5 (2)	2014-04-17
JP2016503797A5 (2)	2016-12-28
JP2013532130A5 (2)	2014-11-06
JP2013032389A5 (2)	2013-03-28
JP2014526533A5 (2)	2015-07-30
JP2014508753A5 (2)	2015-03-05
JP2016540742A5 (2)	2017-12-21
JP2013532687A5 (2)	2014-09-04
JP2011518833A5 (2)	2012-06-14
JP2010095546A5 (2)	2010-12-24
JP2014500861A5 (2)	2014-12-11
JP2015512931A5 (2)	2016-05-26
JP2014506907A5 (2)	2015-04-16
JP2015516427A5 (2)	2016-06-23
JP2015199738A5 (2)	2016-02-18
JP2013102146A5 (ja)	2015-11-05	化合物
JP2015512883A5 (2)	2016-04-28